Recombinant EGFRvIII (Epidermal Growth Factor Receptor, Variant III) Antibody

Biorbyt

Recombinant EGFRvIII (Epidermal Growth Factor Receptor, Variant III) Antibody

10

Positive Control: A431 cells. Placenta, Breast, Colon or Bladder Carcinoma. Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes); Optimal dilution for a specific application should be determined. IHC

ImmunoHistoChemistry

Research Use Only

Monoclonal

GFR/2600R

200 ug/ml

Unconjugated

EGFR

epidermal growth factor receptor

avian erythroblastic leukemia viral (v-erb-b) oncogene homolog; cell growth inhibiting protein 40; cell proliferation-inducing protein 61; epidermal growth factor receptor; epidermal growth factor receptor tyrosine kinase domain; ERBB; ERBB1; erb-b2 receptor tyrosine kinase 1; ERRP; HER1; mENA; NISBD2; PIG61; proto-oncogene c-ErbB-1; receptor tyrosine-protein kinase erbB-1

Rabbit

IgG

Epidermal growth factor receptor

Recombinant EGFRvIII (Epidermal Growth Factor Receptor, Variant III) Antibody

Human

-20°C,2°C to 8°C

12352203